These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 32759352)

  • 1. QuantiFERON-TB Gold Plus with Chemiluminescence Immunoassay: Do We Need a Higher Cutoff?
    Bisognin F; Lombardi G; Re MC; Dal Monte P
    J Clin Microbiol; 2020 Sep; 58(10):. PubMed ID: 32759352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of concordance of new QuantiFERON-TB Gold Plus platforms for
    Ruiz-Tagle C; García P; Hernández M; Balcells ME
    Microbiol Spectr; 2024 Aug; 12(8):e0046924. PubMed ID: 38975791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the Fully Automated Chemiluminescence Analyzer Liaison XL for the Performance of the QuantiFERON-TB Gold Plus Assay in an Area with a Low Incidence of Tuberculosis.
    Fernández-Huerta M; Moreto C; Vila-Olmo N; García de Cara EI; Basaez MC; Santín M; Alcaide F
    J Clin Microbiol; 2021 Jul; 59(8):e0060321. PubMed ID: 34076474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflated Gamma Interferon Response with QuantiFERON-TB Gold Plus Using the Automated Liaison XL Analyzer: a Testing Algorithm To Mitigate False-Positive Results in Low-Incidence Settings.
    Buron V; Banaei N
    J Clin Microbiol; 2023 Jun; 61(6):e0029523. PubMed ID: 37195172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the QuantiFERON-TB Gold Plus and QuantiFERON-TB Gold In-Tube Interferon Gamma Release Assays in Patients at Risk for Tuberculosis and in Health Care Workers.
    Theel ES; Hilgart H; Breen-Lyles M; McCoy K; Flury R; Breeher LE; Wilson J; Sia IG; Whitaker JA; Clain J; Aksamit TR; Escalante P
    J Clin Microbiol; 2018 Jul; 56(7):. PubMed ID: 29743310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative Results of QuantiFERON-TB Gold In-Tube and QuantiFERON-TB Gold Plus Assays for Detection of Tuberculosis Infection in Clinical Samples.
    Won D; Park JY; Kim HS; Park Y
    J Clin Microbiol; 2020 Mar; 58(4):. PubMed ID: 31969422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Impact of Borderline Quantiferon-TB Gold Plus Results for Latent Tuberculosis Screening under Routine Conditions in a Low-Endemicity Setting.
    Wikell A; Jonsson J; Dyrdak R; Henningsson AJ; Eringfält A; Kjerstadius T; Hålldin E; Baqir H; Kholod V; Sturegård E; Bruchfeld J; Schön T
    J Clin Microbiol; 2021 Nov; 59(12):e0137021. PubMed ID: 34550805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the fully automated LIAISON®XL chemiluminescence analyzer for QuantiFERON®-CMV testing in transplant recipients.
    Mafi S; Alain S; Hantz S
    J Clin Virol; 2023 Sep; 166():105550. PubMed ID: 37527584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance of an Advanced Interferon-Gamma Release Assay for Mycobacterium tuberculosis Detection.
    Altawallbeh G; Gabrielson D; Peters JM; Killeen AA
    J Appl Lab Med; 2021 Sep; 6(5):1287-1292. PubMed ID: 33829248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of Recent Tuberculosis Exposure Using QuantiFERON-TB Gold Plus, a Multicenter Study.
    Pérez-Recio S; Pallarès N; Grijota-Camino MD; Sánchez-Montalvá A; Barcia L; Campos-Gutiérrez S; Pomar V; Rabuñal-Rey R; Balcells ME; Gazel D; Montiel N; Vicente D; Goić-Barišić I; Schön T; Paues J; Mareković I; Cacho-Calvo J; Barac A; Goletti D; García-Gasalla M; Barcala JM; Tórtola MT; Anibarro L; Suárez-Toste I; Moga E; Gude-Gonzalez MJ; Naves R; Karslıgil T; Martin-Peñaranda T; Stevanovic G; Trigo M; Rubio V; Karaoğlan İ; Bayram N; Alcaide F; Tebé C; Santin M;
    Microbiol Spectr; 2021 Dec; 9(3):e0097221. PubMed ID: 34756079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance of QuantiFERON-TB Gold Plus for detection of latent tuberculosis infection in pregnant women living in a tuberculosis- and HIV-endemic setting.
    König Walles J; Tesfaye F; Jansson M; Tolera Balcha T; Winqvist N; Kefeni M; Garoma Abeya S; Belachew F; Sturegård E; Björkman P
    PLoS One; 2018; 13(4):e0193589. PubMed ID: 29617458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. QuantiFERON-TB Gold Plus combined with HBHA-Induced IFN-γ release assay improves the accuracy of identifying tuberculosis disease status.
    Tang J; Huang Y; Jiang S; Huang F; Ma T; Qi Y; Ma Y
    Tuberculosis (Edinb); 2020 Sep; 124():101966. PubMed ID: 32866942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of QuantiFERON-TB Gold Plus and QuantiFERON-TB Gold In-Tube tests for patients with active and latent tuberculosis: A prospective cohort study.
    Lee JK; Lee HW; Heo EY; Yim JJ; Kim DK
    J Infect Chemother; 2021 Dec; 27(12):1694-1699. PubMed ID: 34412980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative Evaluation of QuantiFERON-TB Gold In-Tube and QuantiFERON-TB Gold Plus in Diagnosis of Latent Tuberculosis Infection in Immunocompromised Patients.
    Ryu MR; Park MS; Cho EH; Jung CW; Kim K; Kim SJ; Oh HY; Huh W; Jang HR; Koh WJ; Park HY; Kim YH; Sinn DH; Choi JO; Joh JW; Kim JM; Kim SJ; Park JB; Kang ES
    J Clin Microbiol; 2018 Nov; 56(11):. PubMed ID: 30135226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative evaluation of CLIA and EIA for Quantiferon-TB Gold Plus.
    Brantestig S; Kinnunen A; Almeflo S; Restorp K; Ahlqvist J; Dyrdak R
    APMIS; 2020 Apr; 128(4):343-349. PubMed ID: 31976577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of CD8 T-cell in immune response to tuberculosis-specific antigen in QuantiFERON-TB Gold Plus.
    Tsuyuzaki M; Igari H; Okada N; Suzuki K
    J Infect Chemother; 2020 Jun; 26(6):570-574. PubMed ID: 32067903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accuracy of QuantiFERON-TB Gold Plus Test for Diagnosis of Mycobacterium tuberculosis Infection in Children.
    Buonsenso D; Delogu G; Perricone C; Grossi R; Careddu A; De Maio F; Palucci I; Sanguinetti M; Valentini P; Sali M
    J Clin Microbiol; 2020 May; 58(6):. PubMed ID: 32229602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. QuantiFERON-CMV assay by chemiluminescence immunoassay: Is it more suitable for real-live monitoring of transplant patients?
    Fernández-Moreno R; Páez-Vega A; Rodríguez-Cano D; Salinas A; Rodríguez-Cantalejo F; Jurado A; Torre-Cisneros J; Cantisán S
    J Clin Virol; 2024 Apr; 171():105651. PubMed ID: 38346360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance Evaluation of a New Automated Chemiluminescent Immunoanalyzer-Based Interferon-Gamma Releasing Assay AdvanSure I3 in Comparison With the QuantiFERON-TB Gold In-Tube Assay.
    Kim JJ; Park Y; Choi D; Kim HS
    Ann Lab Med; 2020 Jan; 40(1):33-39. PubMed ID: 31432637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First evaluation of QuantiFERON-TB Gold Plus performance in contact screening.
    Barcellini L; Borroni E; Brown J; Brunetti E; Campisi D; Castellotti PF; Codecasa LR; Cugnata F; Di Serio C; Ferrarese M; Goletti D; Lipman M; Rancoita PM; Russo G; Tadolini M; Vanino E; Cirillo DM
    Eur Respir J; 2016 Nov; 48(5):1411-1419. PubMed ID: 27390280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.